
Freddy E. Escorcia MD PhD
Lasker Clinical Investigator, NIH Distinguished Scholar, Head Laboratory of Molecular Radiotherapy, Radiation Oncology Branch, Molecular Imaging Branch, National Cancer Institute
Join to view full profile
1275 York AvenueNew York, NY 10065
Phone+1 212-639-2000
Dr. Escorcia is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- I am a board-certified radiation oncologist and scientist committed to improving the quantity and quality lives of people with cancer.
Clinically, I treat patients with cancers amenable to radiotherapy, with particular interest in cancers of the gut, including liver and pancreas cancers.
For my research, I leverage my expertise in bioengineering, chemistry, pharmacology, and oncology to design, engineer, and test of novel tumor-selective imaging and therapeutic agents for human cancers in general, and liver cancers in particular, with translational intent.
I have brought together motivated trainees, and scientists to form the Laboratory of Molecular Radiotherapy within the Molecular Imaging Branch at the National Cancer Institute, with goals to
1) identify tumor selective targets,
2) discover novel biomolecules specific to targets of interest,
3) design, engineer, and test novel radioconjugates from these biomolecules using in vitro assays and in vivo imaging and therapy studies, and
4) conduct clinical studies using next generation radiopharmaceutical imaging and therapeutic agents.
Education & Training
Memorial Sloan Kettering Cancer CenterResidency, Radiation Oncology, 2013 - 2017
Weill Cornell MedicineClass of 2012
Certifications & Licensure
NY State Medical License 2013 - 2027
American Board of Radiology Radiation Oncology
Publications & Presentations
PubMed
- Glypican-3-Targeted Paired Radiotheranostics in Orthotopic Liver Cancer Models.Woonghee Lee, Joon-Yong Chung, Stephen Adler, Falguni Basuli, Kwamena Baidoo
Clinical Cancer Research. 2026-09-09 - 1 citationsDevelopment of novel GPC2-directed radiotheranostics and CAR T cell therapy for neuroblastoma.Ira Phadke, Divya Nambiar, George Diehl, Joon-Yong Chung, Hima Makala
Molecular Therapy. 2026-09-02 - A radiopharmaceutical enhances CAR T cells against radio-sensitive and radio-resistant neuroblastoma by tumor sensitization and TME remodeling.Constanza Rodriguez, Robert S Edinger, George Diehl, Jeyshka M Reyes-González, Woonghee Lee
Cell Reports. Medicine. 2026-07-21
External Links
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: